How is this undervalued? They are making $9m in product sales while generating $24m in cash operating expenses plus $7 million in R&D per quarter. Yes, sales are growing, but they are living off convertible notes financing. Not healthy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.